CD30-Positive Extracellular Vesicles Enable the Targeting of CD30-Negative DLBCL Cells by the CD30 Antibody-Drug Conjugate Brentuximab Vedotin oleh Liudmila Lobastova, Liudmila Lobastova, Liudmila Lobastova, Liudmila Lobastova, Marcus Lettau, Marcus Lettau, Felix Babatz, Thais Dolzany de Oliveira, Thais Dolzany de Oliveira, Thais Dolzany de Oliveira, Thais Dolzany de Oliveira, Phuong-Hien Nguyen, Phuong-Hien Nguyen, Phuong-Hien Nguyen, Phuong-Hien Nguyen, Bianca Alves Pauletti, Astrid C. Schauss, Horst Dürkop, Ottmar Janssen, Adriana F. Paes Leme, Michael Hallek, Michael Hallek, Michael Hallek, Michael Hallek, Hinrich P. Hansen, Hinrich P. Hansen, Hinrich P. Hansen, Hinrich P. Hansen